Peter Mandl, MD, PhD, answers our questions about his research that shed light on the advantages and disadvantages of implementing imaging techniques into a treat-to-target approach in psoriatic arthritis...
In this video, Monica Richey, MSN, NP, discusses ways to differentiate rheumatologic conditions, which is a topic she is presenting at our Practical Updates in Primary Care 2021 Virtual Series on May 13.
...
He talks about the challenges of treating progressive psoriatic arthritis, why certain patients progress to more severe disease, and how to change medication when needed.
Dactylitis is a hallmark of psoriatic arthritis. To better detect inflammation of anatomical structures in the fingers and to monitor the effects of therapy, a group of researchers developed a new scoring...
W. Benjamin Nowell, PhD, answers our questions about his research on patient beliefs and perceptions relating to methotrexate use in the management of rheumatoid arthritis and psoriatic arthritis.
In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how...
In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how...
Dr Mease, from Swedish Medical Center, discusses his research on an interleukin-17a monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic arthritis.
Dr Mease, from Swedish Medical Center, discusses his research on an interleukin-17a monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic arthritis.
